文献速递淋巴瘤

慢性淋巴细胞白血病中的MED12突变与NOTCH信号传导

MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
PubMed 文献 · Br J Haematol · 2017-08-02

本研究在188例慢性淋巴细胞白血病(CLL)患者中检出13例(6.9%)MED12突变,均聚集于N端,且与未突变IGHV相关(P=0.024)。MED12突变样本中NOTCH1胞内域(NICD)水平升高,且MED12突变与NOTCH1突变在1429例CLL患者中互斥(P=0.011),提示MED12突变可能通过激活NOTCH信号参与CLL发病。

要点

  • 188例CLL中13例(6.9%)存在MED12 N端突变,与未突变IGHV相关(P=0.024)。
  • MED12突变样本中NOTCH1活性形式NICD水平升高。
  • 1429例CLL荟萃分析显示MED12突变与NOTCH1突变互斥(P=0.011)。

核心结论

  • MED12突变可能通过激活NOTCH信号传导参与CLL的发病机制。

研究设计与样本

  • 研究对188例CLL患者的MED12突变进行特征分析,并对1429例CLL患者进行荟萃分析。

主要发现

  • 188例CLL患者中13例(6.9%)检出MED12复发突变,突变聚集于N端。
  • MED12突变与未突变IGHV相关(P=0.024)。
  • 原代CLL样本蛋白分析显示,MED12突变背景下NOTCH1胞内域(NICD)水平升高。
  • 使用特异性CDK8抑制剂发现NICD是Cyclin C-CDK8激酶的靶点。
  • 基于1429例CLL患者的荟萃分析,MED12突变与NOTCH1突变互斥(P=0.011)。

关键数值与推荐

  • MED12突变频率为13/188(6.9%)。
  • MED12突变与未突变IGHV的关联P=0.024。
  • MED12突变与NOTCH1突变互斥的荟萃分析P=0.011,基于1429例CLL患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mutations in the N-terminus of MED12 protein occur at high frequency in uterine leiomyomas and breast fibroepithelial tumours, and are frequently found in chronic lymphocytic leukaemia (CLL). MED12 mutations have been previously linked to aberrant Cyclin C-CDK8 kinase activity, but the exact oncogenic function in CLL is unknown. Here, we characterized MED12 mutations in CLL and identified recurrent mutations in 13 out of 188 CLL patients (6·9%), which clustered in the N-terminus. MED12 mutations were associated with unmutated IGHV (P = 0·024). Protein analysis of NOTCH1 in primary CLL samples revealed increased levels of NOTCH1 intracellular domain (NICD), the active form of NOTCH1, in the context of MED12 mutations. We found evidence that NICD is the target of Cyclin C-CDK8 kinase using a specific CDK8 inhibitor. In line with these findings, MED12 mutations were mutually exclusive to mutations in NOTCH1 in CLL, based on a meta-analysis of 1429 CLL patients (P = 0·011). Our results suggest that MED12 mutations may contribute to CLL pathogenesis by activating NOTCH signalling.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Wu B, Słabicki M, Sellner L, et al. MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia. Br J Haematol. 2017. PMID: 28771672. doi:10.1111/bjh.14869

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。